From the September quarterly activities
• Lower unit cash operating costs1 of US$355/dmt.
So around $6.5m profit for the Dec quarter?
I reckon that’s not that bad but maths wasn’t my strongest subject. So correct me if I’m wrong.
Spodumene Prices, page-28
-
- There are more pages in this discussion • 4,604 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.87 |
Change
0.080(2.87%) |
Mkt cap ! $8.563B | |||
| Open | High | Low | Value | Volume |
| $2.82 | $2.88 | $2.77 | $37.05M | 13.14M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 74 | 251104 | $2.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.87 | 215767 | 33 |
View Market Depth
| Last trade - 14.26pm 31/07/2024 (20 minute delay) ? |
| PLS (ASX) Chart |